Cas13d Knockdown of Lung Protease Ctsl Prevents and Treats SARS-CoV-2 Infection

Scientists described a chemically engineered nanosystem encapsulating CRISPR–Cas13d, developed to specifically target lung protease cathepsin L (Ctsl) messenger RNA to block SARS-CoV-2 infection in mice.